Synageva Biopharma Corp

Alexion Pharmaceuticals, Inc. Puts Up a Premium to Buy Fellow Rare Drug Developer (ALXN)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is buying fellow ultra orphan drug developer Synageva Biopharma Corp (NASDAQ:GEVA) for $8.

PropThink — May 6, 2015, 9:24 AM EDT